KANGO SUJAY 4
4 · MEI Pharma, Inc. · Filed Jul 7, 2022
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
KANGO SUJAY
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-05+87,500→ 87,500 totalExercise: $0.54Exp: 2032-07-05→ Common Stock (87,500 underlying)
Holdings
- 58,334
Stock Option (Right to Buy)
Exercise: $2.69Exp: 2031-11-22→ Common Stock (58,334 underlying)
Footnotes (2)
- [F1]The options will vest in equal monthly installments over twelve months.
- [F2]25,000 options will vest in equal monthly installments over thirty-six months from November 22, 2021 and 33,334 options shall vest in equal monthly installments over twelve months from November 22, 2021.